We then used the p110δ inhibitor PI-3065 to block Treg-mediated immune suppression in mice23, and showed that the therapeutic effects of the combination of LB100 and anti-PD1 on reducing tumour growth and enhancing survival were also observed in the presence of PI-3065 (Fig. 5b). The gene discussed is PIK3CD; the disease is neoplasm.